CN1262668C - 转移核酸通过核被膜的细胞转运系统的用途 - Google Patents
转移核酸通过核被膜的细胞转运系统的用途 Download PDFInfo
- Publication number
- CN1262668C CN1262668C CNB008034478A CN00803447A CN1262668C CN 1262668 C CN1262668 C CN 1262668C CN B008034478 A CNB008034478 A CN B008034478A CN 00803447 A CN00803447 A CN 00803447A CN 1262668 C CN1262668 C CN 1262668C
- Authority
- CN
- China
- Prior art keywords
- dna
- nuclear
- localization signal
- sequence
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Virology (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19900513.3 | 1999-01-08 | ||
| DE19900513 | 1999-01-08 | ||
| DE19933939.2 | 1999-07-20 | ||
| DE19933939A DE19933939A1 (de) | 1999-01-08 | 1999-07-20 | Ausnutzung zelleigener Transportsysteme zum Transfer von Nukleinsäuren durch die Kernhülle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1339068A CN1339068A (zh) | 2002-03-06 |
| CN1262668C true CN1262668C (zh) | 2006-07-05 |
Family
ID=26051245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB008034478A Expired - Fee Related CN1262668C (zh) | 1999-01-08 | 2000-01-03 | 转移核酸通过核被膜的细胞转运系统的用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6521456B1 (enExample) |
| EP (1) | EP1141364A1 (enExample) |
| JP (2) | JP3997056B2 (enExample) |
| CN (1) | CN1262668C (enExample) |
| AU (1) | AU764660B2 (enExample) |
| CA (1) | CA2358040C (enExample) |
| IL (1) | IL143983A0 (enExample) |
| WO (1) | WO2000040742A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030069173A1 (en) * | 1998-03-16 | 2003-04-10 | Life Technologies, Inc. | Peptide-enhanced transfections |
| AU764660B2 (en) * | 1999-01-08 | 2003-08-28 | Lonza Cologne Ag | Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| EP1235914A2 (en) * | 1999-11-24 | 2002-09-04 | Joseph Rosenecker | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| AU2002218151A1 (en) * | 2000-11-24 | 2002-06-03 | Pantheco A/S | Pna analogues |
| AU2002216946A1 (en) * | 2001-01-05 | 2002-07-16 | Pantheco A/S | Modified pna molecules |
| CN100510087C (zh) | 2001-01-10 | 2009-07-08 | 埃麦克萨股份公司 | 模块转染系统 |
| WO2003092735A2 (en) * | 2002-05-01 | 2003-11-13 | Pantheco A/S | Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids |
| US8969543B2 (en) * | 2003-04-03 | 2015-03-03 | Bioneer Corporation | SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof |
| US8324365B2 (en) * | 2003-04-03 | 2012-12-04 | Korea Advanced Institute Of Science And Technology | Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| CN101287835A (zh) * | 2005-08-17 | 2008-10-15 | 株式会社百奥尼 | 用于siRNA细胞内输送的siRNA-亲水性聚合物结合物及其方法 |
| EP1900820A1 (en) * | 2006-09-13 | 2008-03-19 | Amaxa AG | Nuclear transport agent and method for producing said agent |
| CA3097512A1 (en) | 2018-05-18 | 2019-11-21 | F. Hoffmann-La Roche Ag | Targeted intracellular delivery of large nucleic acids |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| JP4074658B2 (ja) * | 1992-04-03 | 2008-04-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 自己構築ポリヌクレオチド送達システム |
| US5574142A (en) | 1992-12-15 | 1996-11-12 | Microprobe Corporation | Peptide linkers for improved oligonucleotide delivery |
| US5631237A (en) | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
| WO1995022618A1 (en) * | 1994-02-22 | 1995-08-24 | Dana-Farber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| EP0753069A1 (en) * | 1994-04-15 | 1997-01-15 | Targeted Genetics Corporation | Gene delivery fusion proteins |
| US5670347A (en) * | 1994-05-11 | 1997-09-23 | Amba Biosciences Llc | Peptide-mediated gene transfer |
| JP4338106B2 (ja) | 1995-06-07 | 2009-10-07 | ライフ テクノロジーズ コーポレーション | ペプチド増強カチオン脂質トランスフェクション |
| DE19541679A1 (de) | 1995-11-08 | 1997-05-15 | Gerhard Dr Friedrich | Nicht virale Gentransfersysteme mit NLS (nuclear localization sequences) und/oder magnetisierbaren Mikropartikeln und das damit verbundene Herstellungsverfahren |
| AUPN741696A0 (en) * | 1996-01-05 | 1996-01-25 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids ii |
| EP0946718A1 (en) * | 1996-12-23 | 1999-10-06 | Gene-Cell | Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells |
| WO1998048051A2 (en) * | 1997-04-18 | 1998-10-29 | Millennium Biotherapeutics, Inc. | Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof |
| AU764660B2 (en) * | 1999-01-08 | 2003-08-28 | Lonza Cologne Ag | Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| US6312956B1 (en) * | 1999-10-01 | 2001-11-06 | Vanderbilt University | Nuclear targeted peptide nucleic acid oligomer |
-
2000
- 2000-01-03 AU AU25337/00A patent/AU764660B2/en not_active Ceased
- 2000-01-03 CA CA002358040A patent/CA2358040C/en not_active Expired - Fee Related
- 2000-01-03 JP JP2000592436A patent/JP3997056B2/ja not_active Expired - Fee Related
- 2000-01-03 IL IL14398300A patent/IL143983A0/xx unknown
- 2000-01-03 US US09/869,875 patent/US6521456B1/en not_active Expired - Fee Related
- 2000-01-03 EP EP00903497A patent/EP1141364A1/de not_active Withdrawn
- 2000-01-03 WO PCT/DE2000/000061 patent/WO2000040742A1/de not_active Ceased
- 2000-01-03 CN CNB008034478A patent/CN1262668C/zh not_active Expired - Fee Related
-
2006
- 2006-07-26 JP JP2006203335A patent/JP2006345867A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1141364A1 (de) | 2001-10-10 |
| JP2002534437A (ja) | 2002-10-15 |
| CN1339068A (zh) | 2002-03-06 |
| JP2006345867A (ja) | 2006-12-28 |
| CA2358040C (en) | 2008-06-10 |
| JP3997056B2 (ja) | 2007-10-24 |
| IL143983A0 (en) | 2002-04-21 |
| AU764660B2 (en) | 2003-08-28 |
| WO2000040742A1 (de) | 2000-07-13 |
| AU2533700A (en) | 2000-07-24 |
| US6521456B1 (en) | 2003-02-18 |
| CA2358040A1 (en) | 2000-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1262668C (zh) | 转移核酸通过核被膜的细胞转运系统的用途 | |
| CN1182247C (zh) | 真核细胞中序列特异性dna重组 | |
| CN1780851A (zh) | 将分子递送到细胞的方法和载体复合物 | |
| JP2019503682A (ja) | 細胞および組織への遺伝子編集タンパク質および組成物の、ベクターなしでの送達 | |
| JP3844656B2 (ja) | 動物細胞の形質転換のための方法 | |
| CN1280616A (zh) | 诱导肿瘤特异性细胞毒性的方法和组合物 | |
| CN1852980A (zh) | 用于神经营养蛋白受体介导的基因送递及作为神经营养蛋白激动剂的重组多肽 | |
| CN1529759A (zh) | 模块转染系统 | |
| JP2002525066A5 (enExample) | ||
| CN1630663A (zh) | 结合蛋白磷酸酶2a的合成的或者天然的肽,其鉴定方法以及用途 | |
| CN1268753C (zh) | 由原核核酸结合蛋白介导的分子物质转移法 | |
| CN1622831A (zh) | 促进核酸转移的方法 | |
| JPWO2017029833A1 (ja) | 動物細胞ゲノム部位特異的外来dna挿入方法及び前記挿入方法を用いて得られる細胞 | |
| CN1522300A (zh) | 新型大酶 | |
| CN102584975A (zh) | 一种核仁定位信号肽及其编码基因和应用 | |
| HK1044797A1 (zh) | 轉移核酸通過核被膜的細胞轉運系統的用途 | |
| CN1292827A (zh) | 核酸转移载体、含有它们的组合物及其应用 | |
| CN1676166A (zh) | 与人表皮生长因子受体egfr特异性结合的配体寡肽 | |
| CN1483040A (zh) | 心锚蛋白重复蛋白基因上游序列、含有该序列的载体及其用途 | |
| CN1323723C (zh) | Tie2受体介导的靶向性肿瘤基因治疗的基因转移系统 | |
| CN1262561C (zh) | 干扰细胞内信号发生的合成多肽 | |
| CN1927402A (zh) | 肿瘤靶向性基因传递非病毒载体的构建与制备 | |
| US20240271121A1 (en) | Compositions and methods for isolating t cell receptors (tcrs) and cells expressing the same | |
| CN1272139A (zh) | 编码能与早老素相互作用的蛋白质的核酸 | |
| CN1668743A (zh) | 将突变转移到靶核酸中的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: AMACOSA STOCK CORPORATION Free format text: FORMER NAME OR ADDRESS: AMACOSA CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: Cologne, Germany Patentee after: Amaxa GmbH Address before: Cologne, Germany Patentee before: Amaxa GmbH |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1044797 Country of ref document: HK |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060705 Termination date: 20100203 |